Literature DB >> 17875198

Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.

R Dickman1, E Schiff, A Holland, C Wright, S R Sarela, B Han, R Fass.   

Abstract

BACKGROUND: The current standard of care in proton pump inhibitor failure is to double the proton pump inhibitor dose, despite limited therapeutic gain. Aims To determine the efficacy of adding acupuncture vs. doubling the proton pump inhibitor dose in gastro-oesophageal reflux disease patients who failed symptomatically on proton pump inhibitors once daily.
METHODS: Thirty patients with classic heartburn symptoms who continued to be symptomatic on standard-dose proton pump inhibitors were enrolled into the study. All participants underwent upper endoscopy while on proton pump inhibitors once daily. Subsequently, patients were randomized to either adding acupuncture to their proton pump inhibitor or doubling the proton pump inhibitor dose over a period of 4 weeks. Acupuncture was delivered twice a week by an expert.
RESULTS: The two groups did not differ in demographic parameters. The acupuncture + proton pump inhibitor group demonstrated a significant decrease in the mean daytime heartburn, night-time heartburn and acid regurgitation scores at the end of treatment when compared with baseline, while the double-dose proton pump inhibitor group did not demonstrate a significant change in their clinical endpoints. Mean general health score was only significantly improved in the acupuncture + proton pump inhibitor group.
CONCLUSION: Adding acupuncture is more effective than doubling the proton pump inhibitor dose in controlling gastro-oesophageal reflux disease-related symptoms in patients who failed standard-dose proton pump inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875198     DOI: 10.1111/j.1365-2036.2007.03520.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

1.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 2.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 3.  Management of the patient with incomplete response to PPI therapy.

Authors:  Peter J Kahrilas; Guy Boeckxstaens; Andre J P M Smout
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-06       Impact factor: 3.043

4.  Effects and possible mechanisms of acupuncture at ST36 on upper and lower abdominal symptoms induced by rectal distension in healthy volunteers.

Authors:  Jinsong Liu; Hong Huang; Xiaohong Xu; J D Z Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-16       Impact factor: 3.619

5.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 6.  Physiology of the upper segment, body, and lower segment of the esophagus.

Authors:  Larry Miller; Pere Clavé; Ricard Farré; Begoña Lecea; Michael R Ruggieri; Ann Ouyang; Julie Regan; Barry P McMahon
Journal:  Ann N Y Acad Sci       Date:  2013-10       Impact factor: 5.691

Review 7.  Gastrointestinal motility disorders and acupuncture.

Authors:  Jieyun Yin; Jiande D Z Chen
Journal:  Auton Neurosci       Date:  2010-04-03       Impact factor: 3.145

8.  Issues of design and statistical analysis in controlled clinical acupuncture trials: an analysis of English-language reports from Western journals.

Authors:  Ping Shuai; Xiao-Hua Zhou; Lixing Lao; Xiaosong Li
Journal:  Stat Med       Date:  2011-02-22       Impact factor: 2.373

Review 9.  Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.

Authors:  Eamonn M M Quigley; Brian E Lacy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

10.  New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.

Authors:  Fehmi Ates; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.